wright giemsa solutions kit Search Results


wright giemsa solutions kit  (Camco Inc)
90
Camco Inc wright giemsa solutions kit
( A ) <t>Wright</t> <t>Giemsa</t> staining showing morphological changes between NAD-treated and control cells after four days. ( B ) Increase in the surface markers CD15, CD14 and CD11b upon NAD treatment ( C ) NBT positive staining detected by small blue dots after counterstaining the cells with safranin. A magnification is shown in the rectangle. ( D ) Seahorse XF analysis of K562 mitochondrial stress response in cells treated with NAD or vehicle. The figure represents the mean of two biological replicates (n=2). Error bars indicate ± S.D. ( E ) Model showing the molecular mechanism of CEBPA gene reactivation by NAD. CEBPA is epigenetically silenced in K562. DNMT1 ensure a constant methylated status of CEBPA promoter (upper part). The NAD supplementation to K562 cell culture, boosts PARP1 to produce ADP-ribose polymers leading to DNMT1 inhibition (bottom part). The ultimate effect is CEPBA re-activated transcription.
Wright Giemsa Solutions Kit, supplied by Camco Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wright+giemsa+solutions+kit/wright+giemsa+solutions+kit/bio_rxiv__2020__07__31__231555-42-7-11
Average 90 stars, based on 1 article reviews
wright giemsa solutions kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Wright Giemsa staining showing morphological changes between NAD-treated and control cells after four days. ( B ) Increase in the surface markers CD15, CD14 and CD11b upon NAD treatment ( C ) NBT positive staining detected by small blue dots after counterstaining the cells with safranin. A magnification is shown in the rectangle. ( D ) Seahorse XF analysis of K562 mitochondrial stress response in cells treated with NAD or vehicle. The figure represents the mean of two biological replicates (n=2). Error bars indicate ± S.D. ( E ) Model showing the molecular mechanism of CEBPA gene reactivation by NAD. CEBPA is epigenetically silenced in K562. DNMT1 ensure a constant methylated status of CEBPA promoter (upper part). The NAD supplementation to K562 cell culture, boosts PARP1 to produce ADP-ribose polymers leading to DNMT1 inhibition (bottom part). The ultimate effect is CEPBA re-activated transcription.

Journal: bioRxiv

Article Title: NAD modulates DNA methylation and cell differentiation

doi: 10.1101/2020.07.31.231555

Figure Lengend Snippet: ( A ) Wright Giemsa staining showing morphological changes between NAD-treated and control cells after four days. ( B ) Increase in the surface markers CD15, CD14 and CD11b upon NAD treatment ( C ) NBT positive staining detected by small blue dots after counterstaining the cells with safranin. A magnification is shown in the rectangle. ( D ) Seahorse XF analysis of K562 mitochondrial stress response in cells treated with NAD or vehicle. The figure represents the mean of two biological replicates (n=2). Error bars indicate ± S.D. ( E ) Model showing the molecular mechanism of CEBPA gene reactivation by NAD. CEBPA is epigenetically silenced in K562. DNMT1 ensure a constant methylated status of CEBPA promoter (upper part). The NAD supplementation to K562 cell culture, boosts PARP1 to produce ADP-ribose polymers leading to DNMT1 inhibition (bottom part). The ultimate effect is CEPBA re-activated transcription.

Article Snippet: The cells were then stained with the Wright Giemsa solutions kit (CAMCO STAIN PAK, pc#702) according to manufacturer’s instructions.

Techniques: Staining, Methylation, Cell Culture, Inhibition